Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...

Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase ...

Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system. Researchers from the Francis Crick ...

SAN DIEGO — CAR T-cell therapies offer the tantalizing prospect of dramatically altering the outcome of lung cancers, but there are many hurdles to treating patients with them, according to experts.

Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Daiichi Sankyo and Merck Launch New Lung Cancer Study With ...

Signalling between neurons and tumour cells in the lung and brain promotes the growth of small-cell lung cancer. These interactions might be a therapeutic target. Read the paper: Neuronal ...

A new blood test can detect lung cancer in real time, enabling earlier diagnosis, quicker treatment, reduced delays, and ...

In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...

A team of UK researchers has developed a pioneering blood test that could enable doctors to detect and monitor lung cancer in real time, which will help reduce diagnostic delays and improve patient ...